Format

Send to:

Choose Destination
See comment in PubMed Commons below
Neuroreport. 2012 Mar 7;23(4):224-7. doi: 10.1097/WNR.0b013e3283500987.

Expression of equilibrative nucleoside transporter type 1 protein in elderly patients with schizophrenia.

Author information

  • 1Department of Psychiatry and Behavioral Neurobiology, School of Medicine, Civitan International Research Center, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Abstract

Alterations in glutamatergic neurotransmission are thought to be involved in several psychiatric disorders, including schizophrenia. Equilibrative nucleoside transporter type 1 (ENT1) regulates glutamate levels by regulating excitatory amino acid transporter expression and activity in the brain. In this study, we investigated whether ENT1 is abnormally expressed in the brain of elderly patients with schizophrenia. We measured protein expression of ENT1 in the superior temporal gyrus (STG) and anterior cingulate cortex (ACC) in patients with schizophrenia (STG, n=22; ACC, n=34) and a comparison group (STG, n=24; ACC, n=29). We found decreased ENT1 expression in the STG in patients with schizophrenia, supporting the hypothesis of altered glutamate transport in this illness.

PMID:
22314683
[PubMed - indexed for MEDLINE]
PMCID:
PMC3685430
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins Icon for PubMed Central
    Loading ...
    Write to the Help Desk